标题
Therapeutic Strategies in the Management of COVID-19
作者
关键词
-
出版物
Frontiers in Molecular Biosciences
Volume 7, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-02-04
DOI
10.3389/fmolb.2020.636738
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- High-Dose Chloroquine for Uncomplicated Plasmodium falciparum Malaria Is Well Tolerated and Causes Similar QT Interval Prolongation as Standard-Dose Chloroquine in Children
- (2020) Johan Ursing et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
- (2020) Huijun Chen et al. LANCET
- Guide to Understanding the 2019 Novel Coronavirus
- (2020) Aditya Shah et al. MAYO CLINIC PROCEEDINGS
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
- (2020) Eva Schrezenmeier et al. Nature Reviews Rheumatology
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
- (2020) Xiaolong Tian et al. Emerging Microbes & Infections
- Protecting health-care workers from subclinical coronavirus infection
- (2020) De Chang et al. Lancet Respiratory Medicine
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Treatment of COVID-19 Patients with Convalescent Plasma
- (2020) Eric Salazar et al. AMERICAN JOURNAL OF PATHOLOGY
- Guidance for the management of adult patients with coronavirus disease 2019
- (2020) Jie-Ming Qu et al. CHINESE MEDICAL JOURNAL
- Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?
- (2020) Maurizio Guastalegname et al. CLINICAL INFECTIOUS DISEASES
- Perinatal Transmission of COVID-19 Associated SARS-CoV-2: Should We Worry?
- (2020) Cuifang Fan et al. CLINICAL INFECTIOUS DISEASES
- Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China
- (2020) Pingzheng Mo et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection
- (2020) Dan Yan et al. EUROPEAN RESPIRATORY JOURNAL
- Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
- (2020) Zahra Sahraei et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
- (2020) Calvin J. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The convalescent sera option for containing COVID-19
- (2020) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- Hydroxychloroquine and Azithromycin to Treat Patients With COVID‐19: Both Friends and Foes?
- (2020) Bruno Mégarbane et al. JOURNAL OF CLINICAL PHARMACOLOGY
- SARS-CoV-2: the emergence of a viral pathogen causing havoc on human existence
- (2020) Ashish Prasad et al. JOURNAL OF GENETICS
- Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
- (2020) Lisi Deng et al. JOURNAL OF INFECTION
- Clinical progression of patients with COVID-19 in Shanghai, China
- (2020) Jun Chen et al. JOURNAL OF INFECTION
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Hydroxychloroquine prophylaxis for COVID-19 contacts in India
- (2020) Sahaj Rathi et al. LANCET INFECTIOUS DISEASES
- COVID-19: faecal–oral transmission?
- (2020) Jordan Hindson Nature Reviews Gastroenterology & Hepatology
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug treatment options for the 2019-new coronavirus (2019-nCoV)
- (2020) Hongzhou Lu BioScience Trends
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
- (2020) Philippe Gautret et al. Travel Medicine and Infectious Disease
- Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
- (2020) Wei Tang et al. BMJ-British Medical Journal
- Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
- (2020) Matthieu Mahévas et al. BMJ-British Medical Journal
- In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses
- (2020) Chang Kyung Kang et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base
- (2020) Fabio S Taccone et al. Lancet Respiratory Medicine
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
- (2020) Erin K McCreary et al. Open Forum Infectious Diseases
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
- (2020) Ka-Tim Choy et al. ANTIVIRAL RESEARCH
- Cyclosporine: an old weapon in the fight against Coronaviruses
- (2020) Adam Molyvdas et al. EUROPEAN RESPIRATORY JOURNAL
- Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression
- (2020) Fang Liu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19
- (2020) Ling Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Early safety indicators of COVID-19 convalescent plasma in 5000 patients
- (2020) Michael J. Joyner et al. JOURNAL OF CLINICAL INVESTIGATION
- No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
- (2020) J.M. Molina et al. MEDECINE ET MALADIES INFECTIEUSES
- Inflammation suppression by dexamethasone via inhibition of CD147-mediated NF-κB pathway in collagen-induced arthritis rats
- (2020) Qishan Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence
- (2020) Myron S. Cohen NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
- (2020) E. Susan Amirian et al. One Health
- COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
- (2020) Young Hun Chung et al. ACS Nano
- Covid-19: Pfizer vaccine efficacy was 52% after first dose and 95% after second dose, paper shows
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Influenza virus polymerase inhibitors in clinical development
- (2019) Frederick G. Hayden et al. CURRENT OPINION IN INFECTIOUS DISEASES
- New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections
- (2019) Erik De Clercq Chemistry-An Asian Journal
- Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis
- (2019) Eleftherios Pelechas et al. Therapeutics and Clinical Risk Management
- Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
- (2018) Min-Han Lin et al. ANTIVIRAL RESEARCH
- Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
- (2018) Jae-Hoon Ko et al. ANTIVIRAL THERAPY
- Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature
- (2018) Clotilde Chatre et al. DRUG SAFETY
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- Hydroxychloroquine retinopathy — implications of research advances for rheumatology care
- (2018) April Jorge et al. Nature Reviews Rheumatology
- Two regimens of dexamethasone versus prednisolone for acute exacerbations in asthmatic Egyptian children
- (2018) Dalia A Elkharwili et al. European Journal of Hospital Pharmacy-Science and Practice
- Increased Incidence of Gastrointestinal Side Effects in Patients Taking Hydroxychloroquine: A Brand-related Issue?
- (2017) AMAR SRINIVASA et al. JOURNAL OF RHEUMATOLOGY
- The clinical development process for a novel preventive vaccine: An overview
- (2016) K Singh et al. Journal of Postgraduate Medicine
- Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion
- (2016) Christopher M. Coleman et al. JOURNAL OF VIROLOGY
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import
- (2016) Veronika Götz et al. Scientific Reports
- Yu Ping Feng San, an Ancient Chinese Herbal Decoction, Induces Gene Expression of Anti-viral Proteins and Inhibits Neuraminidase Activity
- (2015) Crystal Y.Q. Du et al. PHYTOTHERAPY RESEARCH
- Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
- (2014) Julie Dyall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Arbidol as a broad-spectrum antiviral: An update
- (2014) Julie Blaising et al. ANTIVIRAL RESEARCH
- Malarial hemozoin: From target to tool
- (2014) Lorena M. Coronado et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Coronaviruses: Important Emerging Human Pathogens
- (2014) C. M. Coleman et al. JOURNAL OF VIROLOGY
- Favipiravir: A New Medication for the Ebola Virus Disease Pandemic
- (2014) Takashi Nagata et al. Disaster Medicine and Public Health Preparedness
- Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan–Yinqiaosan in the Treatment of H1N1 Influenza
- (2013) Chen Wang et al. ANNALS OF INTERNAL MEDICINE
- Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase
- (2013) Hidehiro Sangawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication
- (2013) Lindsay Lundberg et al. ANTIVIRAL RESEARCH
- Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model
- (2012) Yiwu Yan et al. CELL RESEARCH
- Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug
- (2012) E. Mastrangelo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway
- (2012) P. Elumalai et al. TOXICOLOGY LETTERS
- Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
- (2012) Sandrine Belouzard et al. Viruses-Basel
- Non-nucleosidic inhibition of Herpes simplex virus DNA polymerase: mechanistic insights into the anti-herpetic mode of action of herbal drug withaferin A
- (2011) Abhinav Grover et al. BMC BIOINFORMATICS
- Use of Corticosteroids in Treating Infectious Diseases
- (2008) Steven McGee ARCHIVES OF INTERNAL MEDICINE
- Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion
- (2008) Y. Boriskin et al. CURRENT MEDICINAL CHEMISTRY
- Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV
- (2008) Erik De Clercq INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effects of low dose quercetin: Cancer cell-specific inhibition of cell cycle progression
- (2008) Jae-Hoon Jeong et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Severe hydroxychloroquine myopathy
- (2008) Hoda Abdel-Hamid et al. MUSCLE & NERVE
- A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
- (2008) K. Ratia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS coronavirus replicase proteins in pathogenesis
- (2007) Rachel L. Graham et al. VIRUS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started